Intelligent Feline Health Management System

Publication ID: 24-11857566_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Feline Health Management System,” Published Technical Disclosure No. 24-11857566_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857566_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,566.

Summary of the Inventive Concept

A synergistic system combining a sulfonated polystyrene derivative with AI, IoT, blockchain, and novel materials to treat and prevent cat flu, providing enhanced diagnostic capabilities, personalized treatment, and predictive analytics.

Background and Problem Solved

The original patent disclosed a sulfonated polystyrene derivative for treating cat flu, but it had limitations in terms of diagnostic accuracy, treatment effectiveness, and data management. The new inventive concept addresses these limitations by integrating the derivative with advanced technologies to create a comprehensive feline health management system.

Detailed Description of the Inventive Concept

The system comprises a sulfonated polystyrene derivative of formula I, an AI-powered diagnostic module for identifying feline calicivirus or feline herpesvirus infections, IoT-enabled sensors for tracking vital signs and symptoms, a blockchain-based data storage system for secure and transparent data management, and novel, biodegradable materials for controlled release of the derivative. The system enables personalized treatment, predictive analytics, and real-time monitoring of treatment effectiveness.

Novelty and Inventive Step

The new claims introduce a synergistic combination of the sulfonated polystyrene derivative with AI, IoT, blockchain, and novel materials, which provides a non-obvious and innovative solution for feline health management. The integration of these technologies enables a level of diagnostic accuracy, treatment effectiveness, and data management that is not achievable with the original patent alone.

Alternative Embodiments and Variations

Alternative embodiments of the system could include the use of different AI algorithms, varying IoT sensor configurations, or alternative blockchain platforms. Additionally, the system could be adapted for use in other animal species or human health applications.

Potential Commercial Applications and Market

The Intelligent Feline Health Management System has significant commercial potential in the veterinary and animal health industries, with potential applications in pet care, animal research, and public health. The system's advanced diagnostic capabilities, personalized treatment, and predictive analytics make it an attractive solution for pet owners, veterinarians, and researchers.

Original Patent Information

Patent NumberUS 11,857,566
TitleSulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu
Assignee(s)UNIWERSYTET JAGIELLONSKI